“…To assess the activation of the MAPK3/1 pathway, the cells were stimulated with 10 ng/mL recombinant human FGF2 (PeproTech, Rocky Hill, NJ, USA; more than 97% similarity with bovine FGF2, NP_776481) for 0, 15, 30, 60, and 240 min and total cell protein was harvested for Western blotting. The ability of FGF2 to regulate abundance of mRNA encoding DUSPs was assessed in dose-response and time-course studies; cells were stimulated with 0, 1, 10, or 50 ng/mL FGF2 for 2 h, or treated with FGF2 at 10 ng/mL for 0, 1, 2, 4, or 8 h. To measure the effect of FGF2 on DUSP protein abundance, cells were stimulated with 10 ng/mL FGF2 for 4, 6, 12, and 24 h. These doses and time periods were based on our previous study with FGF2 in sheep granulosa cells (Relav et al 2021).…”